                         SEQUENCE LISTING

<110>  Thomas Jefferson University
 
<120>  Oligodendrocyte-derived Extracellular Vesicles for Therapy of 
       Multiple Sclerosis

<130>  205961-7043WO1(00177)

<150>  62/953,257
<151>  2019-12-24

<150>  62/857,182
<151>  2019-06-04

<160>  8     

<170>  PatentIn version 3.5

<210>  1
<211>  36
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Forward primer - Cre gene

<400>  1
tactagtggc gcgccaccat gcccaagaag aagagg                                 36


<210>  2
<211>  26
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Reverse primer - Cre gene

<400>  2
ggatccagcg taatctggaa catcgt                                            26


<210>  3
<211>  24
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  mMOG sgRNA1 forward

<400>  3
caccgagcaa gcacctgaat accg                                              24


<210>  4
<211>  24
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  mMOG sgRNA1 reverse

<400>  4
aaaccggtat tcaggtgctt gctc                                              24


<210>  5
<211>  25
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  mMOG sgRNA2 forward

<400>  5
caccgtcacc tctaccgaaa tggca                                             25


<210>  6
<211>  25
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  mMOG sgRNA2 reverse

<400>  6
aaactgccat ttcggtagag gtgac                                             25


<210>  7
<211>  20
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  mMOG DP forward

<400>  7
tcccactctt gtgtcttgga                                                   20


<210>  8
<211>  20
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  mMOG DP reverse

<400>  8
agcaggtgta gcctccttca                                                   20


